Skip to main content
. 2013 Apr 30;108(10):2088–2096. doi: 10.1038/bjc.2013.197

Table 1. Patient characteristics (n=187).

Feature Frequency (n, %)
Gender (n=186)
Male 92 (49.5)
Female
94 (50.5)
Age (years)
Mean (min, max)
68.1 (35–93)
Tumor size (mm)
Mean (min, max)
4.5 (1–12)
Histological subtype (n=187)
Non-mucinous 163 (87.2)
Mucinous
24 (12.8)
Tumor location (n=186)
Left-side 115 (61.8)
Right-side 45 (24.2)
Rectum
26 (14.0)
Tumor grade (n=187)
G1–2 118 (63.1)
G3
69 (36.9)
pT (n=187)
pT1–2 49 (26.2)
pT3–4
138 (73.8)
pN (n=187)
pN0 95 (50.8)
pN1–2
92 (49.2)
pM (n=186)
pM0 169 (90.9)
pM1
17 (9.1)
V (n=187)
V+ 29 (15.5)
V−
158 (84.5)
L (n=187)
L+ 75 (40.1)
L−
112 (59.9)
Tumor budding (n=187)
Low-grade 105 (56.2)
High-grade
82 (43.9)
Tumor growth pattern (n=187)
Infiltrating 134 (71.7)
Pushing
53 (28.3)
Post-operative therapy (n=187)
None 69 (36.9)
Chemo 75 (40.1)
Chemo+radio 42 (22.5)
Radio
1 (0.5)
Mismatch repair status (n=186)
Proficient 173 (93.0)
Deficient
13 (7.0)
KRAS mutation (codon 12/13), (n=171)
Wild type 113 (66.1)
Mutated
58 (33.9)
Survival time (n=186)
Months 47 (35–58)